Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
48.0%
% of BBH's 27 holdings also in PBE
42.9%
% of PBE's 28 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in PBE |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 14.1% | 6.7% | 6.7% | |
AMGEN INC | 18.3% | 5.7% | 5.7% | |
REGENERON PHARMACEUTICALS | 6.2% | 4.9% | 4.9% | |
NATERA INC | 3.8% | 4.4% | 3.8% | |
BIOGEN IDEC INC | 3.2% | 4.9% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
AMGEN INC | 12.5% | |
VERTEX PHARMACEUTICALS INC | 12.0% | |
GILEAD SCIENCES INC | 7.4% | |
ARGENX SE ADR | 4.9% | |
IQVIA HOLDINGS INC | 4.3% | |
ALNYLAM PHARMACEUTICALS INC | 3.7% | |
ICON PLC | 3.1% | |
BIONTECH SE SPONSORED ADR | 2.4% | |
BEIGENE LTD. SPONSORED ADR | 2.3% | |
INSMED INC | 2.1% |
BBH Underweight Relative to PBE
UNITED THERAPEUTICS CORP | -4.5% | |
HALOZYME THERAPEUTICS INC | -3.6% | |
AXSOME THERAPEUTICS, INC. | -3.6% | |
ROYALTY PHARMA PLC CLASS A | -3.5% | |
INCYTE CORP | -3.4% | |
TG THERAPEUTICS INC | -3.1% | |
ACADIA PHARMACEUTICALS INC | -3.0% | |
EXELIXIS INC | -3.0% | |
BIOCRYST PHARMACEUTICALS INC | -3.0% | |
CATALYST PHARMACEUTICAL PART | -2.9% |